These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24527796)

  • 21. Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
    Mozes E; Zinger H; Kohn LD; Singer DS
    J Clin Immunol; 1998 Mar; 18(2):106-13. PubMed ID: 9533654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus.
    Graham KL; Lee LY; Higgins JP; Steinman L; Utz PJ; Ho PP
    Arthritis Rheum; 2008 Jul; 58(7):2098-104. PubMed ID: 18576356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reactive T cells in murine lupus: analysis of genetic contributions and development of self-tolerance.
    Kotzin BL; Herron LR; Babcock SK; Portanova JP; Palmer E
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S35-46. PubMed ID: 2571438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice.
    Hirose S; Tokushige K; Kinoshita K; Nozawa S; Saito J; Nishimura H; Shirai T
    Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant genetic control of invariant TCR-bearing NKT cell function in New Zealand mouse strains: possible involvement in systemic lupus erythematosus pathogenesis.
    Tsukamoto K; Ohtsuji M; Shiroiwa W; Lin Q; Nakamura K; Tsurui H; Jiang Y; Sudo K; Nishimura H; Shirai T; Hirose S
    J Immunol; 2008 Apr; 180(7):4530-9. PubMed ID: 18354175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
    J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
    Nomura A; Noto D; Murayama G; Chiba A; Miyake S
    Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
    J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.
    Zhang Y; Saha S; Rosenfeld G; Gonzalez J; Pepeljugoski KP; Peeva E
    J Rheumatol; 2010 Aug; 37(8):1646-57. PubMed ID: 20551107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice.
    Kotzin BL; Palmer E
    J Exp Med; 1987 May; 165(5):1237-51. PubMed ID: 3494806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.
    Mihara M; Tan I; Chuzhin Y; Reddy B; Budhai L; Holzer A; Gu Y; Davidson A
    J Clin Invest; 2000 Jul; 106(1):91-101. PubMed ID: 10880052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition.
    Schiffer L; Sinha J; Wang X; Huang W; von Gersdorff G; Schiffer M; Madaio MP; Davidson A
    J Immunol; 2003 Jul; 171(1):489-97. PubMed ID: 12817034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE).
    Fujimura T; Hirose S; Jiang Y; Kodera S; Ohmuro H; Zhang D; Hamano Y; Ishida H; Furukawa S; Shirai T
    Int Immunol; 1998 Oct; 10(10):1467-72. PubMed ID: 9796913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
    Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
    Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE).
    Suwannaroj S; Lagoo A; Keisler D; McMurray RW
    Lupus; 2001; 10(4):258-65. PubMed ID: 11341102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
    Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
    Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus.
    Vyse TJ; Halterman RK; Rozzo SJ; Izui S; Kotzin BL
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8098-103. PubMed ID: 10393954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
    Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA
    Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.